Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.51% 0.03% 292.06M 200223.4
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.98% 201.0% 170.26M

Basic Info

Investment Strategy
The Fund seeks long-term capital appreciation. Under normal circumstances, the Fund will invest at least 80% of its assets in securities of US health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities.
General
Security Type Exchange-Traded Fund
Equity Style Multi Cap Core
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Health/Biotechnology Funds
Fund Owner Firm Name Simplify
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
--
--
-4.41%
3.80%
8.81%
24.35%
-0.85%
27.67%
15.90%
21.82%
-18.14%
23.79%
18.67%
21.09%
2.32%
4.65%
11.31%
14.58%
-2.16%
-2.18%
9.62%
27.97%
3.95%
26.34%
22.13%
11.81%
-15.24%
3.95%
-4.29%
21.17%
4.17%
22.13%
11.70%
6.13%
2.55%
-1.42%
2.98%
24.16%
6.48%
25.48%
18.85%
23.20%
-9.40%
3.95%
-0.94%
9.52%
3.08%
As of February 20, 2026.

Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.59%
Stock 98.59%
Bond 0.81%
Convertible 0.00%
Preferred 0.00%
Other 0.01%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks long-term capital appreciation. Under normal circumstances, the Fund will invest at least 80% of its assets in securities of US health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities.
General
Security Type Exchange-Traded Fund
Equity Style Multi Cap Core
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Health/Biotechnology Funds
Fund Owner Firm Name Simplify
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders